NASDAQ: ANIP) has closed the acquisition of the NDAs for purified corticotropin gel and
corticotropin-zinc hydroxide from US-based drugmaker Merck for USD 75m in cash and a percentage of future net sales, the company said.
Target: NDAs for purified corticotropin gel and
corticotropin-zinc hydroxideis acquiring the New Drug Applications for purified corticotropin gel and
corticotropin-zinc hydroxide from Merck & Co.
has that it will buy the NDAs for purified corticotropin gel and
corticotropin-zinc hydroxide from Merck (called MSD outside of the United States and Canada) for $75 million in cash and a percentage of future net sales.
NASDAQ: ANIP) has agreed to acquire the NDAs for purified corticotropin gel and
corticotropin-zinc hydroxide from US-based drugmaker Merck for USD75 m in cash and a percentage of future net sales.